Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 37 citing articles:

Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India
Ravikirti, Ranjini Roy, Chandrima Pattadar, et al.
Journal of Pharmacy & Pharmaceutical Sciences (2021) Vol. 24, pp. 343-350
Open Access | Times Cited: 71
Effectiveness of Drug Repurposing and Natural Products Against SARS-CoV-2: A Comprehensive Review
Paula Andrea Cuartas Velásquez, Juan C. Hernández, Elkin Galeano, et al.
Clinical Pharmacology Advances and Applications (2024) Vol. Volume 16, pp. 1-25
Open Access | Times Cited: 10
Systematic review and meta-analysis of ivermectin for treatment of COVID-19: evidence beyond the hype
Milena Soriano Marcolino, Karina Cardoso Meira, Nathália Sernizon Guimarães, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 31
RETRACTED: Effects of a Single Dose of Ivermectin on Viral and Clinical Outcomes in Asymptomatic SARS-CoV-2 Infected Subjects: A Pilot Clinical Trial in Lebanon
Ali Samaha, Hussein Mouawia, Mirna Fawaz, et al.
Viruses (2021) Vol. 13, Iss. 6, pp. 989-989
Open Access | Times Cited: 37
Cheminformatics-Based Study Identifies Potential Ebola VP40 Inhibitors
Emmanuel Broni, Carolyn N. Ashley, Joseph Adams, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6298-6298
Open Access | Times Cited: 16
Combination Treatment With Remdesivir and Ivermectin Exerts Highly Synergistic and Potent Antiviral Activity Against Murine Coronavirus Infection
Yu Ling Tan, Kevin S. W. Tan, Justin Jang Hann Chu, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 29
Is the antiparasitic drug ivermectin a suitable candidate for the treatment of epilepsy?
Wolfgang Löscher
Epilepsia (2023) Vol. 64, Iss. 3, pp. 553-566
Open Access | Times Cited: 13
Recombinant Bacillus Calmette–Guérin Expressing SARS-CoV-2 Chimeric Protein Protects K18-hACE2 Mice against Viral Challenge
Fábio Mambelli, Fábio V. Marinho, Juvana Moreira Andrade, et al.
The Journal of Immunology (2023) Vol. 210, Iss. 12, pp. 1925-1937
Open Access | Times Cited: 11
Antiviral Chemotherapy in Avian Medicine—A Review
Ines Szotowska, Aleksandra Ledwoń
Viruses (2024) Vol. 16, Iss. 4, pp. 593-593
Open Access | Times Cited: 4
Enhancing Intracellular Uptake of Ivermectin through Liposomal Encapsulation
Meryem Kocas, Fumiyoshi Yamashita, Tansel Çomoğlu, et al.
AAPS PharmSciTech (2025) Vol. 26, Iss. 5
Open Access
Extracellular binding sites of positive and negative allosteric P2X4 receptor modulators
Stephanie Weinhausen, Jessica Nagel, Vigneshwaran Namasivayam, et al.
Life Sciences (2022) Vol. 311, pp. 121143-121143
Closed Access | Times Cited: 14
Patch-clamp studies and cell viability assays suggest a distinct site for viroporin inhibitors on the E protein of SARS-CoV-2
Ulrike Breitinger, Christine Adel Sedky, Heinrich Sticht, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 7
Comparative study of the interaction of ivermectin with proteins of interest associated with SARS-CoV-2: A computational and biophysical approach
Lenin González-Paz, María Laura Hurtado-León, Carla Lossada, et al.
Biophysical Chemistry (2021) Vol. 278, pp. 106677-106677
Open Access | Times Cited: 15
COVID-19 and Ivermectin: Potential threats associated with human use
Tean Zaheer, Kaushik Pal, Rao Zahid Abbas, et al.
Journal of Molecular Structure (2021) Vol. 1243, pp. 130808-130808
Open Access | Times Cited: 12
Binding behavior of receptor binding domain of the SARS-CoV-2 virus and ivermectin
Kasidy R. Gossen, Meiyi Zhang, Z̆ivko L. Nikolov, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Ofeleein i mi Vlaptin—Volume II: Immunity Following Infection or mRNA Vaccination, Drug Therapies and Non-Pharmacological Management at Post-Two Years SARS-CoV-2 Pandemic
Jannis Kountouras, Dimitra Gialamprinou, Georgios Kotronis, et al.
Medicina (2022) Vol. 58, Iss. 2, pp. 309-309
Open Access | Times Cited: 6
Ivermectin Inhibits the Replication of Usutu Virus In Vitro
Maria Elisabeth Wald, Claudia Claus, Andréa Cristina Konrath, et al.
Viruses (2022) Vol. 14, Iss. 8, pp. 1641-1641
Open Access | Times Cited: 6
Evaluation of therapeutic potential of ivermectin against complete Freund's adjuvant‐induced arthritis in rats: Involvement of inflammatory mediators
Muhammad Usman Ali Khan, Tasleem Akhtar, Nadia Naseem, et al.
Fundamental and Clinical Pharmacology (2023) Vol. 37, Iss. 5, pp. 971-982
Closed Access | Times Cited: 3
Identifying the Toxidrome of Ivermectin Toxicity
Jon Stewart H Dy, Dan Neftalie A. Juangco
Cureus (2023)
Open Access | Times Cited: 3
Recent advances in avermectin chemistry
Leonid G. Menchikov, М. Х. Джафаров, И. В. Заварзин
Russian Chemical Reviews (2022) Vol. 91, Iss. 9, pp. RCR5051-RCR5051
Closed Access | Times Cited: 5
Use of low-cost adsorbent functionalized with iron oxide nanoparticles for ivermectin removal
Luís Fernando Cusioli, Renata Mariane de Souza, Laiza Bergamasco Beltran, et al.
South African Journal of Chemical Engineering (2023) Vol. 47, pp. 142-149
Open Access | Times Cited: 2
Cardiovascular safety pharmacology of ivermectin assessed using the isoflurane-anesthetized beagle dogs: ICH S7B follow-up study
Norihiro Suzuki, Ryuichi Kambayashi, Ai Goto, et al.
The Journal of Toxicological Sciences (2023) Vol. 48, Iss. 12, pp. 645-654
Open Access | Times Cited: 2
Editorial: Emerging and Re-emerging Vector-borne and Zoonotic Diseases
Alfonso J. Rodríguez‐Morales, Jaime A. Cardona‐Ospina, Matthew H. Collins
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 5
A hitchhiker's guide through the COVID-19 galaxy
Susanna Felsenstein, Andreas Reiff
Clinical Immunology (2021) Vol. 232, pp. 108849-108849
Open Access | Times Cited: 4
Systematic Review and Meta-Analysis of Ivermectin for Treatment of COVID-19: Evidence Beyond the Hype
Milena Soriano Marcolino, Karina Cardoso Meira, Victor Schulthais Chagas, et al.
SSRN Electronic Journal (2022)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top